Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Ardent Health, Inc. (ARDT)

Ardent Health recharacterizes former CEO Bonick's exit as termination for Cause

Neutral Impact 4 of 5 leadership Written later

Ardent Health said its Board found on October 19, 2026 that former CEO Martin J. Bonick failed to fully disclose third-party compensation, and recharacterized his June 2026 separation as a termination for Cause. The company will stop about $4.5 million of unpaid severance and cancel his unvested performance-based restricted stock units, and it reserved its rights to pursue other remedies. The filing says no financial statements or previously disclosed results need revision.

Key points

  • Bonick's employment as President and CEO and his board service ended effective June 2, 2026.
  • On October 19, 2026, the Board determined that facts discovered after the separation date would have supported a termination for Cause.
  • Ardent will discontinue about $4.5 million of unpaid cash severance and cancel or forfeit outstanding unvested PRSUs.
  • The company says none of its financial statements or previously disclosed results need to be revised or corrected.

The filing

CompanyArdent Health, Inc. (ARDT)
Form8-K, current report
Filed with the SECOct 23, 2026, 4:42 PM ET
Accession number0001104659-26-118499

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.